Aspect Biosystems Ltd.

About

Aspect Biosystems Ltd. is a Vancouver biotechnology company developing implantable bioprinted tissue therapeutics for metabolic and endocrine diseases. A company announcement says it was founded in November 2013 and spun out of the University of British Columbia. Its current pipeline page describes pancreatic tissue therapeutics aimed at type 1 diabetes and adrenal tissue therapeutics for primary adrenal insufficiency.

Products

• Adrenal bioprinted tissue therapeutics
  Allogeneic adrenal tissue therapeutic the company places in preclinical development for primary adrenal insufficiency.
• Full-stack tissue therapeutic platform
  Bioprinting platform the company describes as combining computational design, therapeutic cells, and biomaterials to manufacture implantable allogeneic tissues.
• Pancreatic bioprinted tissue therapeutics
  Implantable pancreatic tissue in development from stem-cell islet clusters, intended to sense glucose and release insulin without immune suppression.

Certifications

None listed.

Regions

• Canada

Capabilities

• Business type: Manufacturer
• Year established: 2013
• Categories: Life Sciences & Genomics, Custom Parts

Contact

Website: https://www.aspectbiosystems.com/

Email: [email protected]